de Oliveira Souza R, Duarte Junior J, Della Casa V, Santoro Rosa D, Renia L, Claser C
Front Cell Infect Microbiol. 2024; 14:1421571.
PMID: 39211797
PMC: 11358129.
DOI: 10.3389/fcimb.2024.1421571.
Amaral J, Taylor P, Schoen R
Rev Soc Bras Med Trop. 2024; 57:e00404.
PMID: 38597523
PMC: 11000508.
DOI: 10.1590/0037-8682-0433-2023.
Matcuk Jr G, Katal S, Gholamrezanezhad A, Spinnato P, Waldman L, Fields B
Skeletal Radiol. 2024; 53(10):2099-2120.
PMID: 38240759
PMC: 11371866.
DOI: 10.1007/s00256-024-04589-4.
Amaral J, Lucena G, Schoen R
Curr Rheumatol Rev. 2024; 20(3):337-346.
PMID: 38173199
DOI: 10.2174/0115733971278715231208114037.
Avila-Trejo A, Rodriguez-Paez L, Alcantara-Farfan V, Aguilar-Faisal J
Int J Mol Sci. 2023; 24(17).
PMID: 37685893
PMC: 10488091.
DOI: 10.3390/ijms241713087.
Duration of West Nile Virus Immunoglobulin M Antibodies up to 81 Months Following West Nile Virus Disease Onset.
Staples J, Gibney K, Panella A, Prince H, Basile A, Laven J
Am J Trop Med Hyg. 2022; .
PMID: 35405658
PMC: 9209930.
DOI: 10.4269/ajtmh.21-1234.
Post-chikungunya arthritis: a longitudinal study in a tertiary care hospital in Bangladesh.
Hossain S, Choudhury M, Islam M, Hassan M, Yeasmin S, Hossain F
Trop Med Health. 2022; 50(1):21.
PMID: 35260197
PMC: 8903658.
DOI: 10.1186/s41182-022-00412-9.
Distinct Cellular Tropism and Immune Responses to Alphavirus Infection.
Kafai N, Diamond M, Fox J
Annu Rev Immunol. 2022; 40:615-649.
PMID: 35134315
PMC: 10350340.
DOI: 10.1146/annurev-immunol-101220-014952.
Mosquito-bite infection of humanized mice with chikungunya virus produces systemic disease with long-term effects.
Hibl B, Dailey Garnes N, Kneubehl A, Vogt M, Clinton J, Rico-Hesse R
PLoS Negl Trop Dis. 2021; 15(6):e0009427.
PMID: 34106915
PMC: 8189471.
DOI: 10.1371/journal.pntd.0009427.
Insights into Antibody-Mediated Alphavirus Immunity and Vaccine Development Landscape.
Torres-Ruesta A, Chee R, Ng L
Microorganisms. 2021; 9(5).
PMID: 33922370
PMC: 8145166.
DOI: 10.3390/microorganisms9050899.
Post-Chikungunya Virus Infection Musculoskeletal Disorders: Syndromic Sequelae after an Outbreak.
Imad H, Matsee W, Kludkleeb S, Asawapaithulsert P, Phadungsombat J, Nakayama E
Trop Med Infect Dis. 2021; 6(2).
PMID: 33921055
PMC: 8167736.
DOI: 10.3390/tropicalmed6020052.
Long-Term Persistence of Serum-Specific Anti-Chikungunya IgM Antibody - A Case Series of Brazilian Patients.
Costa D, Coelho M, Gouveia P, Bezerra L, Lopes Marques C, Duarte A
Rev Soc Bras Med Trop. 2021; 54:e0855.
PMID: 33886823
PMC: 8047711.
DOI: 10.1590/0037-8682-0855-2020.
Epidemiologic and clinical investigations during a chikungunya outbreak in Rio Grande do Norte State, Brazil.
Monteiro J, Valverde J, Morais I, Souza C, Fagundes Neto J, de Melo M
PLoS One. 2020; 15(11):e0241799.
PMID: 33216743
PMC: 7678967.
DOI: 10.1371/journal.pone.0241799.
Chikungunya infection in pregnancy - reassuring maternal and perinatal outcomes: a retrospective observational study.
Foeller M, Nosrat C, Krystosik A, Noel T, Gerardin P, Cudjoe N
BJOG. 2020; 128(6):1077-1086.
PMID: 33040457
PMC: 8035284.
DOI: 10.1111/1471-0528.16562.
Immunopathogenesis of alphaviruses.
Baxter V, Heise M
Adv Virus Res. 2020; 107:315-382.
PMID: 32711733
PMC: 8224468.
DOI: 10.1016/bs.aivir.2020.06.002.
Promising application of monoclonal antibody against chikungunya virus E1-antigen across genotypes in immunochromatographic rapid diagnostic tests.
Suzuki K, Huits R, Phadungsombat J, Tuekprakhon A, Nakayama E, van den Berg R
Virol J. 2020; 17(1):90.
PMID: 32615978
PMC: 7330967.
DOI: 10.1186/s12985-020-01364-4.
Disease Resolution in Chikungunya-What Decides the Outcome?.
Srivastava P, Kumar A, Hasan A, Mehta D, Kumar R, Sharma C
Front Immunol. 2020; 11:695.
PMID: 32411133
PMC: 7198842.
DOI: 10.3389/fimmu.2020.00695.
A comparison of Chikungunya virus infection, progression, and cytokine profiles in human PMA-differentiated U937 and murine RAW264.7 monocyte derived macrophages.
Guerrero-Arguero I, Hoj T, Tass E, Berges B, Robison R
PLoS One. 2020; 15(3):e0230328.
PMID: 32163514
PMC: 7067478.
DOI: 10.1371/journal.pone.0230328.
Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection.
Kumar R, Shrivastava T, Samal S, Ahmed S, Parray H
Appl Microbiol Biotechnol. 2020; 104(8):3209-3228.
PMID: 32076776
PMC: 7223553.
DOI: 10.1007/s00253-020-10437-x.
Methotrexate an Old Drug with New Tricks.
Bedoui Y, Guillot X, Selambarom J, Guiraud P, Giry C, Jaffar-Bandjee M
Int J Mol Sci. 2019; 20(20).
PMID: 31658782
PMC: 6834162.
DOI: 10.3390/ijms20205023.